Table 5.
Performance of noninvasive parameters for identifying high risk EV among 39 patients complicated with EV
| Characteristic | Cutoff | AUC (95 % CI) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Positive Likelihood ratio | Negative Likelihood ratio | Accuracy (%) |
|---|---|---|---|---|---|---|---|---|---|
| LSPS | 4.5 | 0.859 (0.736–0.981) | 70.0 | 86.2 | 63.6 | 89.3 | 5.08 | 0.35 | 82.1 |
| Platelet count (×109/l) | 100 | 0.833 (0.707–0.958) | 100.0 | 65.5 | 50.0 | 100.0 | 2.61 | 0.00 | 74.3 |
| Platelet-to-spleen ratio | 990 | 0.817 (0.687–0.947) | 100.0 | 65.5 | 50.0 | 100.0 | 2.90 | 0.00 | 74.3 |
| LS (kPa) | 12.0 | 0.807 (0.674–0.940) | 80.0 | 75.9 | 53.3 | 91.7 | 3.31 | 0.31 | 76.9 |
| APRI | 1.7 | 0.762 (0.609–0.915) | 80.0 | 72.4 | 50.0 | 91.3 | 2.90 | 0.28 | 74.4 |
| FIB-4 | 5.0 | 0.716 (0.529–0.902) | 90.0 | 58.6 | 42.9 | 94.4 | 2.18 | 0.17 | 66.7 |